Lawrence Nycum

OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian,…

Journal of Clinical Oncology · 2012 · Last of 9 authors · 1,048 citations

Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian cancer

Gynecologic Oncology · 2015 · 245 citations